| Interactions between Microbiome and DME (MICBIO)
|
| Bacteria: Actinobacteria |
| Bifidobacterium adolescentis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bifidobacterium adolescentis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bifidobacterium breve (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bifidobacterium breve co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bifidobacterium breve co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Ranitidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1393
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bifidobacterium breve co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bifidobacterium breve co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bifidobacterium longum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bifidobacterium longum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bifidobacterium longum co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Bifidobacterium ruminatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Alprenolol |
Click to Show/Hide the Detail |
| Drug ID |
DR0076
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bifidobacterium ruminatum co-metabolize the drug Alprenolol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Bupropion |
Click to Show/Hide the Detail |
| Drug ID |
DR0247
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bifidobacterium ruminatum co-metabolize the drug Bupropion, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bifidobacterium ruminatum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluvoxamine maleate |
Click to Show/Hide the Detail |
| Drug ID |
DR0740
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bifidobacterium ruminatum co-metabolize the drug Fluvoxamine maleate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Metoprolol tartrate |
Click to Show/Hide the Detail |
| Drug ID |
DR1072
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bifidobacterium ruminatum co-metabolize the drug Metoprolol tartrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bifidobacterium ruminatum co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Collinsella aerofaciens (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Loxapine succinate |
Click to Show/Hide the Detail |
| Drug ID |
DR0989
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Collinsella aerofaciens co-metabolize the drug Loxapine succinate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Nefazodone |
Click to Show/Hide the Detail |
| Drug ID |
DR1135
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Collinsella aerofaciens co-metabolize the drug Nefazodone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Collinsella intestinalis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Collinsella intestinalis co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Collinsella intestinalis co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Eggerthella lenta (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Dopamine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0532
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Eggerthella lenta co-metabolize the drug Dopamine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [14] |
| Mycobacterium tuberculosis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Dextromethorphan hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0476
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Mycobacterium tuberculosis co-metabolize the drug Dextromethorphan hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [16] |
| Nocardia farcinica (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Nocardia farcinica co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [18] |
| Streptomyces griseus (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Doxorubicin |
Click to Show/Hide the Detail |
| Drug ID |
DR0546
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Streptomyces griseus co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [20] |
| Bacteria: Bacteroidetes |
| Alistipes indistinctus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Alistipes indistinctus co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Alistipes indistinctus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Alistipes indistinctus co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Alistipes indistinctus co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Alistipes indistinctus co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Alistipes indistinctus co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Alistipes indistinctus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Bacteroides caccae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Nefazodone |
Click to Show/Hide the Detail |
| Drug ID |
DR1135
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides caccae co-metabolize the drug Nefazodone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides caccae co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides caccae co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Tegaserod |
Click to Show/Hide the Detail |
| Drug ID |
DR1541
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides caccae co-metabolize the drug Tegaserod, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Bacteroides cellulosilyticus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides cellulosilyticus co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides cellulosilyticus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Bacteroides coprophilus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides coprophilus co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides coprophilus co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides coprophilus co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Galantamine hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0761
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides coprophilus co-metabolize the drug Galantamine hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides coprophilus co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Olanzapine |
Click to Show/Hide the Detail |
| Drug ID |
DR1186
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides coprophilus co-metabolize the drug Olanzapine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides coprophilus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 12 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides dorei co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides dorei co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides dorei co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Doxazosin |
Click to Show/Hide the Detail |
| Drug ID |
DR0542
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides dorei co-metabolize the drug Doxazosin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides dorei co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides dorei co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluphenazine decanoate |
Click to Show/Hide the Detail |
| Drug ID |
DR0722
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides dorei co-metabolize the drug Fluphenazine decanoate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides dorei co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides dorei co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides dorei co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides dorei co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides dorei co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Bacteroides eggerthii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides eggerthii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides eggerthii co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides eggerthii co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides eggerthii co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides eggerthii co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides eggerthii co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Bacteroides finegoldii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides finegoldii co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 16 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides fragilis co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides fragilis co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides fragilis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Galantamine hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0761
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides fragilis co-metabolize the drug Galantamine hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Lofexidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0967
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides fragilis co-metabolize the drug Lofexidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides fragilis co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Metoprolol tartrate |
Click to Show/Hide the Detail |
| Drug ID |
DR1072
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides fragilis co-metabolize the drug Metoprolol tartrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides fragilis co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Olanzapine |
Click to Show/Hide the Detail |
| Drug ID |
DR1186
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides fragilis co-metabolize the drug Olanzapine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides fragilis co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Ranitidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1393
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides fragilis co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides fragilis co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides fragilis co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides fragilis co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Sotalol |
Click to Show/Hide the Detail |
| Drug ID |
DR1501
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides fragilis co-metabolize the drug Sotalol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides fragilis co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Bacteroides intestinalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides intestinalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides intestinalis co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides intestinalis co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Bacteroides ovatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides ovatus co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides ovatus co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides ovatus co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides ovatus co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides ovatus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Galantamine hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0761
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides ovatus co-metabolize the drug Galantamine hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides ovatus co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Sotalol |
Click to Show/Hide the Detail |
| Drug ID |
DR1501
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides ovatus co-metabolize the drug Sotalol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides ovatus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Bacteroides sartorii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 16 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides sartorii co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides sartorii co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides sartorii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides sartorii co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides sartorii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluphenazine decanoate |
Click to Show/Hide the Detail |
| Drug ID |
DR0722
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides sartorii co-metabolize the drug Fluphenazine decanoate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Galantamine hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0761
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides sartorii co-metabolize the drug Galantamine hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides sartorii co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides sartorii co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Nicergoline |
Click to Show/Hide the Detail |
| Drug ID |
DR1145
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides sartorii co-metabolize the drug Nicergoline, which can collectively affect efficacy, safety or bioavailability of this drug. |
[37], [2] |
| Penbutolol |
Click to Show/Hide the Detail |
| Drug ID |
DR1249
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides sartorii co-metabolize the drug Penbutolol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides sartorii co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides sartorii co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Sotalol |
Click to Show/Hide the Detail |
| Drug ID |
DR1501
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides sartorii co-metabolize the drug Sotalol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides sartorii co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides sartorii co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Bacteroides stercoris (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides stercoris co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides stercoris co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides stercoris co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides stercoris co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides stercoris co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides stercoris co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 10 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides thetaiotaomicron co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides thetaiotaomicron co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides thetaiotaomicron co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides thetaiotaomicron co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Galantamine hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0761
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides thetaiotaomicron co-metabolize the drug Galantamine hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides thetaiotaomicron co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides thetaiotaomicron co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides thetaiotaomicron co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Sotalol |
Click to Show/Hide the Detail |
| Drug ID |
DR1501
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides thetaiotaomicron co-metabolize the drug Sotalol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides thetaiotaomicron co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Bacteroides uniformis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides uniformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides uniformis co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides uniformis co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Bacteroides vulgatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 10 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides vulgatus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluphenazine decanoate |
Click to Show/Hide the Detail |
| Drug ID |
DR0722
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides vulgatus co-metabolize the drug Fluphenazine decanoate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Imatinib mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0858
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides vulgatus co-metabolize the drug Imatinib mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides vulgatus co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides vulgatus co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Penbutolol |
Click to Show/Hide the Detail |
| Drug ID |
DR1249
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides vulgatus co-metabolize the drug Penbutolol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides vulgatus co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides vulgatus co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides vulgatus co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides vulgatus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides xylanisolvens co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides xylanisolvens co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides xylanisolvens co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides xylanisolvens co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides xylanisolvens co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides xylanisolvens co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides xylanisolvens co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides xylanisolvens co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Odoribacter splanchnicus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Odoribacter splanchnicus co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Odoribacter splanchnicus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Odoribacter splanchnicus co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Odoribacter splanchnicus co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Olanzapine |
Click to Show/Hide the Detail |
| Drug ID |
DR1186
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Odoribacter splanchnicus co-metabolize the drug Olanzapine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Odoribacter splanchnicus co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Odoribacter splanchnicus co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Odoribacter splanchnicus co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Odoribacter splanchnicus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Parabacteroides distasonis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Parabacteroides distasonis co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Parabacteroides distasonis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluphenazine decanoate |
Click to Show/Hide the Detail |
| Drug ID |
DR0722
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Parabacteroides distasonis co-metabolize the drug Fluphenazine decanoate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Parabacteroides distasonis co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Parabacteroides distasonis co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Nicergoline |
Click to Show/Hide the Detail |
| Drug ID |
DR1145
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Parabacteroides distasonis co-metabolize the drug Nicergoline, which can collectively affect efficacy, safety or bioavailability of this drug. |
[37], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Parabacteroides distasonis co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Parabacteroides distasonis co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Parabacteroides distasonis co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Parabacteroides johnsonii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Parabacteroides johnsonii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Parabacteroides johnsonii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Ranitidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1393
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Parabacteroides johnsonii co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Parabacteroides johnsonii co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Parabacteroides johnsonii co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Parabacteroides merdae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Parabacteroides merdae co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Parabacteroides merdae co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Parabacteroides merdae co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Parabacteroides merdae co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Prevotella copri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Prevotella copri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluphenazine decanoate |
Click to Show/Hide the Detail |
| Drug ID |
DR0722
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Prevotella copri co-metabolize the drug Fluphenazine decanoate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Prevotella copri co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Sotalol |
Click to Show/Hide the Detail |
| Drug ID |
DR1501
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Prevotella copri co-metabolize the drug Sotalol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Prevotella copri co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Bacteria: Firmicutes |
| Anaerobutyricum hallii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Anaerobutyricum hallii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Anaerobutyricum hallii co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Anaerobutyricum hallii co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Anaerococcus hydrogenalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Anaerococcus hydrogenalis co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Anaerococcus hydrogenalis co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Anaerostipes hadrus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Fluphenazine decanoate |
Click to Show/Hide the Detail |
| Drug ID |
DR0722
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Anaerostipes hadrus co-metabolize the drug Fluphenazine decanoate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Imatinib mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0858
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Anaerostipes hadrus co-metabolize the drug Imatinib mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Anaerotruncus colihominis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Anaerotruncus colihominis co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Pimozide |
Click to Show/Hide the Detail |
| Drug ID |
DR1291
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Anaerotruncus colihominis co-metabolize the drug Pimozide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Anaerotruncus colihominis co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bacillus megaterium (firmicutes) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacillus megaterium co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[39], [40] |
| Buspirone |
Click to Show/Hide the Detail |
| Drug ID |
DR0248
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacillus megaterium co-metabolize the drug Buspirone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[41], [40], [42] |
| CCRIS-9277 |
Click to Show/Hide the Detail |
| Drug ID |
DR1089
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacillus megaterium co-metabolize the drug CCRIS-9277, which can collectively affect efficacy, safety or bioavailability of this drug. |
[43], [40] |
| Chlorzoxazone |
Click to Show/Hide the Detail |
| Drug ID |
DR0312
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacillus megaterium co-metabolize the drug Chlorzoxazone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[44], [45], [40] |
| Dextromethorphan hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0476
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacillus megaterium co-metabolize the drug Dextromethorphan hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [40] |
| Nifedipine |
Click to Show/Hide the Detail |
| Drug ID |
DR1152
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacillus megaterium co-metabolize the drug Nifedipine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[46], [45], [40] |
| Progesterone |
Click to Show/Hide the Detail |
| Drug ID |
DR1346
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacillus megaterium co-metabolize the drug Progesterone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[47], [42] |
| Propranolol hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1367
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacillus megaterium co-metabolize the drug Propranolol hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[48], [42] |
| Bacillus subtilis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Nitrofural |
Click to Show/Hide the Detail |
| Drug ID |
DR1168
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacillus subtilis co-metabolize the drug Nitrofural, which can collectively affect efficacy, safety or bioavailability of this drug. |
[49], [50], [51] |
| Bacteroides pectinophilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides pectinophilus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Bacteroides pectinophilus co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Blautia hansenii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 15 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Blautia hansenii co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Cyclobenzaprine |
Click to Show/Hide the Detail |
| Drug ID |
DR0390
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Blautia hansenii co-metabolize the drug Cyclobenzaprine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[52], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Blautia hansenii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Doxazosin |
Click to Show/Hide the Detail |
| Drug ID |
DR0542
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Blautia hansenii co-metabolize the drug Doxazosin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Blautia hansenii co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Blautia hansenii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluphenazine decanoate |
Click to Show/Hide the Detail |
| Drug ID |
DR0722
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Blautia hansenii co-metabolize the drug Fluphenazine decanoate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Fluvoxamine maleate |
Click to Show/Hide the Detail |
| Drug ID |
DR0740
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Blautia hansenii co-metabolize the drug Fluvoxamine maleate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Blautia hansenii co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Blautia hansenii co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Nevirapine |
Click to Show/Hide the Detail |
| Drug ID |
DR1142
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Blautia hansenii co-metabolize the drug Nevirapine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[53], [2] |
| Nicergoline |
Click to Show/Hide the Detail |
| Drug ID |
DR1145
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Blautia hansenii co-metabolize the drug Nicergoline, which can collectively affect efficacy, safety or bioavailability of this drug. |
[37], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Blautia hansenii co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Blautia hansenii co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Sildenafil citrate |
Click to Show/Hide the Detail |
| Drug ID |
DR1481
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Blautia hansenii co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Blautia luti (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Blautia luti co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Blautia luti co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Clostridioides difficile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridioides difficile co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[39], [54] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridioides difficile co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Nicergoline |
Click to Show/Hide the Detail |
| Drug ID |
DR1145
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridioides difficile co-metabolize the drug Nicergoline, which can collectively affect efficacy, safety or bioavailability of this drug. |
[37], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridioides difficile co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Sildenafil citrate |
Click to Show/Hide the Detail |
| Drug ID |
DR1481
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridioides difficile co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 17 Drugs Metabolized
|
| Cyclobenzaprine |
Click to Show/Hide the Detail |
| Drug ID |
DR0390
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium botulinum co-metabolize the drug Cyclobenzaprine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[52], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium botulinum co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Doxazosin |
Click to Show/Hide the Detail |
| Drug ID |
DR0542
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium botulinum co-metabolize the drug Doxazosin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium botulinum co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium botulinum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluvoxamine maleate |
Click to Show/Hide the Detail |
| Drug ID |
DR0740
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium botulinum co-metabolize the drug Fluvoxamine maleate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium botulinum co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Metamfetamine |
Click to Show/Hide the Detail |
| Drug ID |
DR1036
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium botulinum co-metabolize the drug Metamfetamine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[55], [56] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium botulinum co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Nevirapine |
Click to Show/Hide the Detail |
| Drug ID |
DR1142
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium botulinum co-metabolize the drug Nevirapine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[53], [2] |
| Nicergoline |
Click to Show/Hide the Detail |
| Drug ID |
DR1145
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium botulinum co-metabolize the drug Nicergoline, which can collectively affect efficacy, safety or bioavailability of this drug. |
[37], [2] |
| Paroxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1245
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium botulinum co-metabolize the drug Paroxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Penbutolol |
Click to Show/Hide the Detail |
| Drug ID |
DR1249
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium botulinum co-metabolize the drug Penbutolol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Pimozide |
Click to Show/Hide the Detail |
| Drug ID |
DR1291
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium botulinum co-metabolize the drug Pimozide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium botulinum co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium botulinum co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Sildenafil citrate |
Click to Show/Hide the Detail |
| Drug ID |
DR1481
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium botulinum co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Clostridium scindens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium scindens co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium scindens co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Clostridium spiroforme (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium spiroforme co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Clostridium sporogenes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium sporogenes co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Celecoxib |
Click to Show/Hide the Detail |
| Drug ID |
DR0286
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium sporogenes co-metabolize the drug Celecoxib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium sporogenes co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium sporogenes co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium sporogenes co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium sporogenes co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium sporogenes co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Clostridium symbiosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium symbiosum co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Clostridium symbiosum co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Coprococcus comes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Coprococcus comes co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Coprococcus comes co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Dorea formicigenerans (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Dorea formicigenerans co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Enterocloster asparagiformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterocloster asparagiformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Nefazodone |
Click to Show/Hide the Detail |
| Drug ID |
DR1135
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterocloster asparagiformis co-metabolize the drug Nefazodone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterocloster asparagiformis co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterocloster asparagiformis co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Enterocloster bolteae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterocloster bolteae co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Pimozide |
Click to Show/Hide the Detail |
| Drug ID |
DR1291
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterocloster bolteae co-metabolize the drug Pimozide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterocloster bolteae co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Enterococcus casseliflavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Nitrofural |
Click to Show/Hide the Detail |
| Drug ID |
DR1168
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterococcus casseliflavus co-metabolize the drug Nitrofural, which can collectively affect efficacy, safety or bioavailability of this drug. |
[49], [59] |
| Enterococcus faecalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterococcus faecalis co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[39], [54] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterococcus faecalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Levodopa |
Click to Show/Hide the Detail |
| Drug ID |
DR0939
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterococcus faecalis co-metabolize the drug Levodopa, which can collectively affect efficacy, safety or bioavailability of this drug. |
[60], [14], [61] |
| Ranitidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1393
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterococcus faecalis co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterococcus faecalis co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Enterococcus gallinarum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Nitrofural |
Click to Show/Hide the Detail |
| Drug ID |
DR1168
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterococcus gallinarum co-metabolize the drug Nitrofural, which can collectively affect efficacy, safety or bioavailability of this drug. |
[49], [59] |
| Enterococcus malodoratus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metamfetamine |
Click to Show/Hide the Detail |
| Drug ID |
DR1036
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterococcus malodoratus co-metabolize the drug Metamfetamine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[55], [56] |
| Erysipelatoclostridium ramosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Erysipelatoclostridium ramosum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Eubacterium rectale (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Eubacterium rectale co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Eubacterium rectale co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Eubacterium rectale co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Eubacterium ventriosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Eubacterium ventriosum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluphenazine decanoate |
Click to Show/Hide the Detail |
| Drug ID |
DR0722
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Eubacterium ventriosum co-metabolize the drug Fluphenazine decanoate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Holdemanella biformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Holdemanella biformis co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Celecoxib |
Click to Show/Hide the Detail |
| Drug ID |
DR0286
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Holdemanella biformis co-metabolize the drug Celecoxib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Holdemanella biformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Holdemanella biformis co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Penbutolol |
Click to Show/Hide the Detail |
| Drug ID |
DR1249
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Holdemanella biformis co-metabolize the drug Penbutolol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Holdemanella biformis co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Hungatella hathewayi (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Ranitidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1393
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Hungatella hathewayi co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Hungatella hathewayi co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Lactobacillus acetotolerans (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metamfetamine |
Click to Show/Hide the Detail |
| Drug ID |
DR1036
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Lactobacillus acetotolerans co-metabolize the drug Metamfetamine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[55], [56] |
| Lactobacillus brevis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Levodopa |
Click to Show/Hide the Detail |
| Drug ID |
DR0939
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Lactobacillus brevis co-metabolize the drug Levodopa, which can collectively affect efficacy, safety or bioavailability of this drug. |
[60], [61] |
| Lactobacillus reuteri (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Lactobacillus reuteri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Marvinbryantia formatexigens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Marvinbryantia formatexigens co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Roseburia intestinalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Roseburia intestinalis co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Roseburia intestinalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluphenazine decanoate |
Click to Show/Hide the Detail |
| Drug ID |
DR0722
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Roseburia intestinalis co-metabolize the drug Fluphenazine decanoate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Roseburia intestinalis co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Roseburia intestinalis co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Roseburia intestinalis co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ruminococcus gnavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Ruminococcus gnavus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Ruminococcus gnavus co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ruminococcus lactaris (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Ruminococcus lactaris co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Ruminococcus lactaris co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Ruminococcus lactaris co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ruminococcus torques (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Ruminococcus torques co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Staphylococcus aureus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Nitrofural |
Click to Show/Hide the Detail |
| Drug ID |
DR1168
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Staphylococcus aureus co-metabolize the drug Nitrofural, which can collectively affect efficacy, safety or bioavailability of this drug. |
[49], [62], [63] |
| Subdoligranulum variabile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Subdoligranulum variabile co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Subdoligranulum variabile co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Subdoligranulum variabile co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Subdoligranulum variabile co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Bacteria: Lentisphaerae |
| Victivallis vadensis (PVC bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Victivallis vadensis co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Victivallis vadensis co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Bacteria: Proteobacteria |
| Acidovorax ebreus (beta-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Cefalexin |
Click to Show/Hide the Detail |
| Drug ID |
DR0284
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Acidovorax ebreus co-metabolize the drug Cefalexin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[64], [65] |
| Citrobacter freundii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Citrobacter freundii co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[39], [54] |
| Enterobacter cancerogenus (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterobacter cancerogenus co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterobacter cancerogenus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterobacter cancerogenus co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Enterobacter cancerogenus co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 13 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Escherichia coli co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[39], [54] |
| Amphetamine |
Click to Show/Hide the Detail |
| Drug ID |
DR0106
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Escherichia coli co-metabolize the drug Amphetamine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [67] |
| Bupropion |
Click to Show/Hide the Detail |
| Drug ID |
DR0247
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Escherichia coli co-metabolize the drug Bupropion, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Doxorubicin |
Click to Show/Hide the Detail |
| Drug ID |
DR0546
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Escherichia coli co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [68] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Escherichia coli co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Escherichia coli co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluphenazine decanoate |
Click to Show/Hide the Detail |
| Drug ID |
DR0722
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Escherichia coli co-metabolize the drug Fluphenazine decanoate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Escherichia coli co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Escherichia coli co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [69] |
| Nicergoline |
Click to Show/Hide the Detail |
| Drug ID |
DR1145
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Escherichia coli co-metabolize the drug Nicergoline, which can collectively affect efficacy, safety or bioavailability of this drug. |
[37], [2] |
| Nitrofural |
Click to Show/Hide the Detail |
| Drug ID |
DR1168
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Escherichia coli co-metabolize the drug Nitrofural, which can collectively affect efficacy, safety or bioavailability of this drug. |
[49], [70], [71] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Escherichia coli co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Escherichia coli co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Helicobacter pylori (epsilon-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Levodopa |
Click to Show/Hide the Detail |
| Drug ID |
DR0939
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Helicobacter pylori co-metabolize the drug Levodopa, which can collectively affect efficacy, safety or bioavailability of this drug. |
[60], [72] |
| Klebsiella pneumoniae (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Doxorubicin |
Click to Show/Hide the Detail |
| Drug ID |
DR0546
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Klebsiella pneumoniae co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [68] |
| Proteus penneri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Proteus penneri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Providencia alcalifaciens (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Providencia alcalifaciens co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Providencia rettgeri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Providencia rettgeri co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Providencia stuartii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Providencia stuartii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Providencia stuartii co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Pseudomonas putida (gamma-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Nicotine |
Click to Show/Hide the Detail |
| Drug ID |
DR1148
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Pseudomonas putida co-metabolize the drug Nicotine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[73], [74] |
| Raoultella planticola (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Doxorubicin |
Click to Show/Hide the Detail |
| Drug ID |
DR0546
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Raoultella planticola co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [68] |
| Salmonella enterica (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Salmonella enterica co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Nicergoline |
Click to Show/Hide the Detail |
| Drug ID |
DR1145
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Salmonella enterica co-metabolize the drug Nicergoline, which can collectively affect efficacy, safety or bioavailability of this drug. |
[37], [2] |
| Roxatidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1447
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Salmonella enterica co-metabolize the drug Roxatidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Bacteria: Verrucomicrobia |
| Akkermansia muciniphila (verrucomicrobiae) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Pimozide |
Click to Show/Hide the Detail |
| Drug ID |
DR1291
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Akkermansia muciniphila co-metabolize the drug Pimozide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
| Fungi: Ascomycota |
| Saccharomyces cerevisiae (ascomycota) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) metabolizes the drug Acetaminophen, and Saccharomyces cerevisiae further metabolizes its metabolite (1-Phenyl-1,2-propanedione), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[39], [54] |
| Archaea: Euryarchaeota |
| Methanobrevibacter oralis (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Methanobrevibacter oralis co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [75] |
| Methanobrevibacter smithii (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Methanobrevibacter smithii co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [75] |
| Methanomassiliicoccus luminyensis (thermoplasmata) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Methanomassiliicoccus luminyensis co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [75] |
| Methanosphaera stadtmanae (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 2D6 (CYP2D6) and Methanosphaera stadtmanae co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [75] |
|
|
|
|
|
|